$2.44
2.52% yesterday
Nasdaq, Sep 04, 10:00 pm CET

Rapid Micro Biosystems Inc - Ordinary Shares - Class A Stock price

$2.44
-1.05 30.09% 1M
-0.03 1.21% 6M
+1.54 171.11% YTD
+1.60 190.48% 1Y
-1.05 30.09% 3Y
-18.96 88.60% 5Y
-18.96 88.60% 10Y
-18.96 88.60% 20Y
Nasdaq, Closing price Thu, Sep 04 2025
+0.06 2.52%

Key metrics

Basic
Market capitalization
$105.2m
Enterprise Value
$74.2m
Net debt
positive
Cash
$31.3m
Shares outstanding
44.1m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
3.5 | 3.2
EV/Sales
2.5 | 2.3
EV/FCF
negative
P/B
1.9
Financial Health
Equity Ratio
76.8%
Return on Equity
-62.2%
ROCE
-77.9%
ROIC
-132.3%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$30.3m | $32.7m
EBITDA
$-42.7m | $-43.1m
EBIT
$-46.1m | $-46.1m
Net Income
$-44.1m | $-44.3m
Free Cash Flow
$-38.3m
Growth (TTM | estimate)
Revenue
22.5% | 16.6%
EBITDA
16.4% | 7.4%
EBIT
15.1% | 7.6%
Net Income
12.6% | 5.6%
Free Cash Flow
18.1%
Margin (TTM | estimate)
Gross
7.5%
EBITDA
-141.0% | -131.7%
EBIT
-152.1%
Net
-145.6% | -135.3%
Free Cash Flow
-126.4%
More
EPS
$-1.0
FCF per Share
$-0.9
Short interest
2.6%
Employees
163
Rev per Employee
$170.0k
Show more

Is Rapid Micro Biosystems Inc - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Rapid Micro Biosystems Inc - Ordinary Shares - Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Rapid Micro Biosystems Inc - Ordinary Shares - Class A forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a Rapid Micro Biosystems Inc - Ordinary Shares - Class A forecast:

Buy
90%
Hold
10%

Financial data from Rapid Micro Biosystems Inc - Ordinary Shares - Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
30 30
23% 23%
100%
- Direct Costs 28 28
1% 1%
92%
2.28 2.28
165% 165%
8%
- Selling and Administrative Expenses 34 34
6% 6%
114%
- Research and Development Expense 14 14
1% 1%
46%
-43 -43
16% 16%
-141%
- Depreciation and Amortization 3.39 3.39
6% 6%
11%
EBIT (Operating Income) EBIT -46 -46
15% 15%
-152%
Net Profit -44 -44
13% 13%
-146%

In millions USD.

Don't miss a Thing! We will send you all news about Rapid Micro Biosystems Inc - Ordinary Shares - Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Rapid Micro Biosystems Inc - Ordinary Shares - Class A Stock News

Neutral
GlobeNewsWire
2 days ago
LEXINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will present at the H.C.Wainwright 27th Annual Global Investment C...
Neutral
Seeking Alpha
23 days ago
Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q2 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Michael Beaulieu - Vice President of Investor Relations & Corporate Communications Robert G. Spignesi - CEO, President & Director Sean M.
Neutral
GlobeNewsWire
24 days ago
LEXINGTON, Mass., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the second quarter ended June 30, 2025.
More Rapid Micro Biosystems Inc - Ordinary Shares - Class A News

Company Profile

Rapid Micro Biosystems, Inc. is an innovative life sciences technology company. It provides mission critical automation solutions to facilitate the efficient manufacturing and safe release of healthcare products such as biologics, vaccines, cell & gene therapies, and sterile injectable. The company was founded by Donald Straus in 2006 and is headquartered in Lowell, MA.

Head office United States
CEO Robert Spignesi
Employees 163
Founded 2006
Website www.rapidmicrobio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today